Next-Gen Cas12a System Revolutionizes Precise Single and Multiplexed Gene Editing in Cancer
Australian Researchers Pioneer Next-Generation CRISPR-Cas12a Gene-Editing Tool in Preclinical Models In a groundbreaking growth, Australian researchers have successfully introduced an enhanced version of the Cas12a gene-editing enzyme in mice, marking a notable leap forward in genetic manipulation for cancer and medical research. Published in Nature communications, the study, titled “Advancing the genetic engineering toolbox by … Read more